Radiation recall after capecitabine in a patient with recurrent nasopharyngeal carcinoma: a case report.

about

The role of long noncoding RNA-LET in cell proliferation and invasion of nasopharyngeal carcinoma and its mechanism.

P2860

Q33768785-581B73E0-78B6-450C-B44E-F03402C9D3AF

P2860

Radiation recall after capecitabine in a patient with recurrent nasopharyngeal carcinoma: a case report.

Item

http://www.wikidata.org/entity/Q41040753

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Radiation recall after capecit ...... geal carcinoma: a case report.

@en

type

Item

label

Radiation recall after capecit ...... geal carcinoma: a case report.

@en

prefLabel

Radiation recall after capecit ...... geal carcinoma: a case report.

@en

P1476

Radiation recall after capecit ...... ngeal carcinoma: a case report

@en

P2093

Dora Kwong

http://www.w3.org/2001/XMLSchema#string

To-Wai Leung

http://www.w3.org/2001/XMLSchema#string

P2860

Lapatinib plus capecitabine for HER2-positive advanced breast cancer.

Angiogenic factor

Phase II study of capecitabine and cisplatin combination as first-line chemotherapy in Chinese patients with metastatic nasopharyngeal carcinoma.

Phase II trial of capecitabine plus cisplatin as first-line therapy in patients with metastatic nasopharyngeal cancer.

Treatment outcome of docetaxel, capecitabine and cisplatin regimen for patients with refractory and relapsed nasopharyngeal carcinoma who failed previous platinum-based chemotherapy.

Characterizing the phenomenon of radiation recall dermatitis.

Radiation-recall skin disorders associated with the use of antineoplastic drugs. Pathogenesis, prevalence, and management.

Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group.

Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer.

Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacy.

P2888

s13256-016-1033-1

P304

247

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1186/S13256-016-1033-1

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Victor Ho Fun Lee

Ka On Lam

P577

2016-09-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1044215765

http://www.w3.org/2001/XMLSchema#string

P698

27604462

http://www.w3.org/2001/XMLSchema#string

P932

5015341

http://www.w3.org/2001/XMLSchema#string

Radiation recall after capecitabine in a patient with recurrent nasopharyngeal carcinoma: a case report.

about

P2860

P2860

Radiation recall after capecitabine in a patient with recurrent nasopharyngeal carcinoma: a case report.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P932